CONTEXT: People with chronic obstructive pulmonary disease experience dyspnea with activities despite optimal medical management. OBJECTIVES: The purpose of this study was to test the efficacy of two 12-month dyspnea self-management programs (DSMPs), Internet-based (eDSMP) and face-to-face (fDSMP), compared with a general health education (GHE) control on the primary outcome of dyspnea with activities. METHODS:Participants with chronic obstructive pulmonary disease were randomized to eDSMP (n=43), fDSMP (n=41), or GHE (n=41). The content of the DSMPs were similar and focused on education, skills training, and coaching on dyspnea self-management strategies, including exercise, and only differed in the delivery mode. Dyspnea with activities was measured with the Chronic Respiratory Questionnaire at three, six, and 12 months. Secondary outcomes included exercise behavior and performance, health-related quality of life, self-efficacy for dyspnea management, and perception of support for exercise. The study was registered at Clinicaltrials.gov (NCT00461162). RESULTS: There were no differences in dyspnea with activities across groups over 12 months (P=0.48). With the exception of arm endurance (P=0.04), exercise behavior, performance, and health-related quality of life did not differ across groups (P>0.05). Self-efficacy for managing dyspnea improved for the DSMPs compared with GHE (P=0.06). DSMP participants perceived high levels of support for initiating and maintaining an exercise program. CONCLUSION: The DSMPs did not significantly reduce dyspnea with activities compared with attention control. However, the high participant satisfaction with the DSMPs combined with positive changes in other outcomes, including self-efficacy for managing dyspnea and exercise behavior, highlight the need for additional testing of individually tailored technology-enabled interventions to optimize patient engagement and improve clinically relevant outcomes.
RCT Entities:
CONTEXT: People with chronic obstructive pulmonary disease experience dyspnea with activities despite optimal medical management. OBJECTIVES: The purpose of this study was to test the efficacy of two 12-month dyspnea self-management programs (DSMPs), Internet-based (eDSMP) and face-to-face (fDSMP), compared with a general health education (GHE) control on the primary outcome of dyspnea with activities. METHODS:Participants with chronic obstructive pulmonary disease were randomized to eDSMP (n=43), fDSMP (n=41), or GHE (n=41). The content of the DSMPs were similar and focused on education, skills training, and coaching on dyspnea self-management strategies, including exercise, and only differed in the delivery mode. Dyspnea with activities was measured with the Chronic Respiratory Questionnaire at three, six, and 12 months. Secondary outcomes included exercise behavior and performance, health-related quality of life, self-efficacy for dyspnea management, and perception of support for exercise. The study was registered at Clinicaltrials.gov (NCT00461162). RESULTS: There were no differences in dyspnea with activities across groups over 12 months (P=0.48). With the exception of arm endurance (P=0.04), exercise behavior, performance, and health-related quality of life did not differ across groups (P>0.05). Self-efficacy for managing dyspnea improved for the DSMPs compared with GHE (P=0.06). DSMPparticipants perceived high levels of support for initiating and maintaining an exercise program. CONCLUSION: The DSMPs did not significantly reduce dyspnea with activities compared with attention control. However, the high participant satisfaction with the DSMPs combined with positive changes in other outcomes, including self-efficacy for managing dyspnea and exercise behavior, highlight the need for additional testing of individually tailored technology-enabled interventions to optimize patient engagement and improve clinically relevant outcomes.
Authors: Holger J Schünemann; Lauren Griffith; Roman Jaeschke; Roger Goldstein; David Stubbing; Peggy Austin; Gordon H Guyatt Journal: Chest Date: 2003-10 Impact factor: 9.410
Authors: T Effing; E M Monninkhof; P D L P M van der Valk; J van der Palen; C L A van Herwaarden; M R Partidge; E H Walters; G A Zielhuis Journal: Cochrane Database Syst Rev Date: 2007-10-17
Authors: Claude Sicotte; Guy Paré; Sandra Morin; Jacques Potvin; Marie-Pierre Moreault Journal: Telemed J E Health Date: 2011-01-09 Impact factor: 3.536
Authors: Huong Q Nguyen; DorAnne Donesky-Cuenco; Seth Wolpin; Lynn F Reinke; Joshua O Benditt; Steven M Paul; Virginia Carrieri-Kohlman Journal: J Med Internet Res Date: 2008-04-16 Impact factor: 5.428
Authors: Anke Lenferink; Marjolein Brusse-Keizer; Paul Dlpm van der Valk; Peter A Frith; Marlies Zwerink; Evelyn M Monninkhof; Job van der Palen; Tanja W Effing Journal: Cochrane Database Syst Rev Date: 2017-08-04
Authors: Michael L Stellefson; Jonathan J Shuster; Beth H Chaney; Samantha R Paige; Julia M Alber; J Don Chaney; P S Sriram Journal: Health Commun Date: 2017-09-05
Authors: Adam E Singer; Joy R Goebel; Yan S Kim; Sydney M Dy; Sangeeta C Ahluwalia; Megan Clifford; Elizabeth Dzeng; Claire E O'Hanlon; Aneesa Motala; Anne M Walling; Jaime Goldberg; Daniella Meeker; Claudia Ochotorena; Roberta Shanman; Mike Cui; Karl A Lorenz Journal: J Palliat Med Date: 2016-08-17 Impact factor: 2.947
Authors: Viola Voncken-Brewster; Huibert Tange; Hein de Vries; Zsolt Nagykaldi; Bjorn Winkens; Trudy van der Weijden Journal: BMC Public Health Date: 2013-06-07 Impact factor: 3.295
Authors: Michael Stellefson; Beth Chaney; Adam E Barry; Enmanuel Chavarria; Bethany Tennant; Kim Walsh-Childers; P S Sriram; Justin Zagora Journal: J Med Internet Res Date: 2013-02-14 Impact factor: 5.428